7 mins Abingdon Health is expanding its manufacturing capacity at its headquarters in York. The investment will provide state-of-the-art automation for the manufacture of rapid testing solutions. Abin...
Fluorotelomer product manufacturers AGC, Daikin Industries, Johnson Controls and Dynax have formed the Alliance for Telomer Chemistry Stewardship (ATCS) to promote the responsible production, use and management of these chemistries. The alliance will also take a risk-based approach to the regulation of these products.
US-headquartered gene therapy company Asklepios BioPharmaceutical has acquired Paris-based gene therapy company BrainVectis, a spin out from the French National Institute for Health and Medical Research.
Global pharma major AstraZeneca is collaborating with UK biotechnology company Silence Therapeutics to discover, develop and commercialise small interfering RNA (siRNA) therapeutics for cardiovascular, renal, metabolic and respiratory diseases.
Spanish multinational pharmaceutical and chemical manufacturer Grifols is buying three ciprofloxacin-based assets from bankrupt US antibiotics developer Aradigm for $3m.
German chemicals giant BASF saw both sales and profits decline in 2019 as its upstream chemical businesses suffered.
Alexios Chronis, from CSols, examines if it is possible to cut corners when adopting a new informatics implementation project
UK life science company Abcam, headquartered in Cambridge, and University College London spinout SomaServe have joined forces to commercialise the latter’s polymer-based ‘bioic’ nanoparticles which can carry a range of products to live cells.